Corticosteroids boost survival rates for COVID-19 patients
Four papers have been published reinforcing evidence that steroids can significantly improve the outcomes for those critically ill with the virus
Read More
Tag: REMAP-CAP
Celltrion’s infliximab biosimilar to be tested for COVID-19
Infliximab has been chosen because of its effective role in treating autoimmune and inflammatory conditions and established safety profile
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
